Your session is about to expire
← Back to Search
Narrative Exposure Therapy for PTSD in Homeless Women
N/A
Recruiting
Research Sponsored by Rush University Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
Study Summary
This trial will study how to improve the health of homeless women with PTSD+SUD who often suffer with severe illness and early death.
Who is the study for?
This trial is for women over 18 who are currently or recently homeless, have problematic substance use, and suffer from trauma-related distress. They must have experienced a traumatic event and show signs of PTSD. Women can't join if they don't meet these specific conditions.Check my eligibility
What is being tested?
The study tests Narrative Exposure Therapy (NET+) immediately versus after a waiting period for women with PTSD and substance use disorders. It aims to see how effective NET+ is in reducing the health consequences of untreated trauma among homeless women.See study design
What are the potential side effects?
While the description doesn’t specify side effects, psychological therapies like NET+ may sometimes cause temporary increases in distress as individuals confront traumatic memories during treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Post-Traumatic Stress Disorder Symptoms
Secondary outcome measures
Anxiety
Depression
Sleep Problems
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate NET+Experimental Treatment1 Intervention
Receives NET+ immediately
Group II: Waitlist NET+Active Control1 Intervention
Receives NET+ after waitlist
Find a Location
Who is running the clinical trial?
Rush University Medical CenterLead Sponsor
422 Previous Clinical Trials
163,451 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
322 Previous Clinical Trials
401,713 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,800 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I identify as a woman.I am able to understand and decide to participate in this study.
Research Study Groups:
This trial has the following groups:- Group 1: Immediate NET+
- Group 2: Waitlist NET+
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any remaining opportunities to join this experiment?
"As per clinicaltrials.gov, this trial is still actively recruiting participants since its inception on April 12th 2023 and the latest update being made on May 15th of the same year."
Answered by AI
How many volunteers are actively participating in this clinical research?
"Affirmative. The study, which was initially posted on April 12th 2023, is currently searching for participants; the details of this trial have been recently updated as of May 15th 2023. This clinical trial has 2 sites and requires 50 volunteers in total."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger